AB2 BIO

AB2 Bio Ltd located at the innovation park of the école polytechnique fédérale de lausanne (epfl), is a drug discovery and development company focused on developing “best in class” innovative therapies for the treatment of inflammatory diseases with large unmet medical needs inflammation is a natural defense mechanism. However, dysregulated and persistent inflammatory processes are the basis of several chronic inflammatory and autoimmune diseases, such as: nlrc4 - mas, adult onset still'... s disease, chronic obstructive pulmonary disease and many others ab2 bio is developing drugs that will not only treat the symptoms but also target the underlying causes of inflammation-based diseases extensive phase i and ib clinical trials demonstrated a high tolerance and an excellent safety profile of their drug. They have advanced clinical programs in nlrc4 mas and in adult onset still’s disease.

#SimilarOrganizations #People #Website #More

AB2 BIO

Industry:

Biotechnology Health Care Medical Therapeutics

Founded:

2010-01-01

Address:

Lausanne, Vaud, Switzerland

Country:

Switzerland

Website Url:

http://www.ab2bio.com

Total Employee:

Status:

Active

Contact:

+41216938280

Email Addresses:

[email protected]

Total Funding:

58 M CHF

Technology used in webpage:

SPF Google Font API Google Analytics Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS AJAX Libraries API Sectigo SSL